Resources
Use Cases:
New Frontiers: Harnessing Advanced Data Science to Understand the Impact of Medical Congresses on HCPs
Access the PDF Use Case.
At a Glance
- Enhanced Intelligence: Drug-GPT’s AI-driven analysis offers a comprehensive view of congress discussions.
- Informed Decision-Making: Empower Med Comms agencies to provide end clients with actionable intelligence.
- Robust Quality and Compliance Standards: High standards in quality and ethics.
Objective
Medical Comms agencies can harness the Advanced Data Science and AI capabilities of Talking Medicines Drug-GPT to unlock intelligence regarding Medical Congress events. The primary purpose is to deliver actionable insights to end clients, including:
- Share of Voice Analysis: Measure and compare mentions of medicines by therapeutic use across competitive set.
- Drivers of Conversational Themes: Identify key topics and emerging trends from discussions.
- Topic and Sentiment Analysis: Understand topics and scientific discussions pre/during/post congress.
- Longitudinal HCP Sentiment Tracking: Monitor HCP sentiment over time through curated data.
Drug-GPT Capabilities
Ingestion and curation of diverse 1st, 2nd and/or 3rd party data sources:
- Raw data from the Medical Congress itself.
- Unstructured Open and Closed Community Conversational data.
This data is curated with Advanced Data Science and AI technologies, enabling a deeper understanding of the impact of Medical Congresses on HCPs – through surfacing Persona Development, Audience Intelligence and Message Alignment. KPIs can be established and tracked over time with measurement.
Deliverables
Customer-Specific PPT Deck:
- Tailored to answer specific end client questions.
- Clear visual representation of key findings, insights, and trends.
Online access to Drug-GPT Platform:
- Enables qualitative exploration of the curated dataset.
- Provides reliable answers adhering to the highest standards of quality and compliance.
Conclusion
By integrating Drug-GPT, Med Comms agencies can elevate their congress analysis offerings, allowing them to understand the impact of Medical Congresses on HCPs – which adds significant value to end clients. By working across an annual program with Drug-GPT, the Med Comms agencies can maximize efficiency and effectiveness of their congress insights.
Contact Britt Gibson, Manager Global Customer Engagement, at [email protected].